UBE2L3 functions as an oncogene and contributes to the proliferation and apoptosis resistance of tumor cells by suppressing the glycogen synthase kinase 3 beta (GSK3β)/p65 pathway in HCC 13. This evidence concerns the gene GSK3B and hepatocellular carcinoma.